Company Quick10K Filing
Cyren
10-Q 2021-03-31 Filed 2021-05-17
10-K 2020-12-31 Filed 2021-03-30
10-Q 2020-09-30 Filed 2020-11-16
10-Q 2020-06-30 Filed 2020-08-12
10-Q 2020-03-31 Filed 2020-05-13
10-K 2019-12-31 Filed 2020-03-30
10-Q 2019-09-30 Filed 2019-11-13
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-03-28
20-F 2017-12-31 Filed 2018-04-27
20-F 2016-12-31 Filed 2017-04-27
20-F 2015-12-31 Filed 2016-03-31
20-F 2014-12-31 Filed 2015-04-30
20-F 2013-12-31 Filed 2014-04-30
20-F 2012-12-31 Filed 2013-04-25
20-F 2011-12-31 Filed 2012-03-29
20-F 2010-12-31 Filed 2011-06-07
20-F 2009-12-31 Filed 2010-03-26
8-K 2021-02-22
8-K 2021-02-11
8-K 2021-02-10
8-K 2021-01-26
8-K 2021-01-08
8-K 2020-11-16
8-K 2020-08-12
8-K 2020-07-30
8-K 2020-06-01
8-K 2020-05-13
8-K 2020-04-24
8-K 2020-03-25
8-K 2020-03-19
8-K 2020-03-16
8-K 2019-11-13
8-K 2019-11-07
8-K 2019-10-04
8-K 2019-09-11
8-K 2019-08-14
8-K 2019-07-30
8-K 2019-05-20
8-K 2019-05-15
8-K 2019-04-23
8-K 2019-02-20
8-K 2019-02-13
8-K 2019-01-10

Cyren Financials

CYRN Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-03-312019-06-302019-09-30
Cash20,8685,1373,75711,06316,37910,62123,98118,15613,03913,00810,117
Accounts Receivable2,8385,9965,1784,4443,8493,0612,8903,6583,0243,0263,499
Inventory
PP&E8857,93110,05310,89812,04612,89014,97112,6044,6924,6254,437
Assets39,53459,13350,93351,47354,40547,53264,23660,02764,16863,82260,324
Accounts Payable5519588596466037641,0171,6681,2708451,402
Long-Term Debt8,7248,3417,993
Liabilities10,71024,41122,62420,41417,05715,79417,13528,16736,79840,04140,045
Stockholders' Equity28,82434,72228,30931,05937,34831,73847,10131,86027,37023,78120,279
Income Statement ($'000)2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-03-312019-06-302019-09-30
Revenue9,6559,7119,496
Cost of Revenue4,0003,7893,712
Gross Profit5,6555,9225,784
R&D4,1774,2973,516
SG&A6,2885,9885,511
Tax-39-41-37
Net Income-4,576-4,573-3,530
Cash Flow ($'000)2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-03-312019-06-302019-09-30
Cash Operating-1,329782-1,711
Cash Investing-1,171-1,214-1,335
Cash Financing-2,491323231